Peripheral blood cell ratios as prognostic factors in canine diffuse large B‐cell lymphoma treated with CHOP protocol

Diffuse large B‐cell lymphoma (DLBCL) is the most common haematopoietic tumour in dogs and recognized as clinical model for its human counterpart. Recently, neutrophil‐to‐lymphocyte (NLR) and lymphocyte‐to‐monocyte (LMR) ratios have been shown to predict time‐to‐progression (TTP) and lymphoma‐specif...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Veterinary & comparative oncology 2021-06, Vol.19 (2), p.242-252
Hauptverfasser:	Henriques, Joaquim, Felisberto, Ricardo, Constantino‐Casas, Fernando, Cabeçadas, José, Dobson, Jane
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antineoplastic Combined Chemotherapy Protocols Blood Cells Cyclophosphamide diffuse‐large‐B‐cell dog Dog Diseases - diagnosis Dog Diseases - drug therapy Dogs Doxorubicin lymphoma Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, Large B-Cell, Diffuse - veterinary Neutrophils neutrophil‐to‐lymphocyte platelet‐to‐neutrophil Prednisone Prognosis Retrospective Studies Vincristine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!